Dr Ricarda Finnern

Dr Ricarda Finnern, Chief Scientific Officer, joined LenioBio in 2019 from Bayer AG, where she was leading several global development programs for biologics and small molecules in oncology and cardiovascular and nephrological indications.

Ricarda is a molecular biologist and immunologist by training and has over 25 years of experience in academia, contract research organizations, and the pharmaceutical industry.